Sandoz Offers Further Financials Ahead Of Spinoff

Supplement To Listing Prospectus Includes Combined And Pro-Forma First-Half Statements

 
• By David Wallace
  
Spinoff spelled out in letters on orange cubes against yellow background
Sandoz’s spinoff from Novartis is rapidly approaching • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business